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Preface
Premenopausal women experience menstrual cycles, which are accompanied by
fluctuations in reproductive hormones. As many women now participate in sports
activities for health promotion, weight management, social association, and personal
reasons, the interest in the effect of the menstrual cycle phase on physiological
responses during exercise has increased. As the menstrual cycle phase is known to have
effects on physiological responses such as substrate metabolism, body temperature
regulation, and endocrine response at rest, it is not difficult to consider the effect of the
menstrual cycle phase on physiological responses during exercise. Investigating the
physiological responses over several menstrual cycles during exercise may help to avoid
the risk of injury and damage, or to improve health and exercise performance. In the
present study, we set 2 challenges to investigate the effect of the menstrual cycle phase
on physiological response during prolonged exercise under hot conditions. One is to
investigate the influence of the menstrual cycle and water ingestion on physiological
response, whereas the other is to assess the influence of the menstrual cycle and
carbohydrate ingestion on inflammatory response.
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Chapter1. The effect of the menstrual cycle and water ingestion on physiological
responses during prolonged exercise under hot conditions
1. Background
In women with a normal menstrual cycle, core temperature changes periodically,
increasing by 0.3°0.5°C in the luteal phase as compared with the follicular phase [1].
Previous studies have suggested that progesterone and estradiol are involved in core
temperature regulation in women [2,3]. Although details of the mechanism underlying
thermoregulation via these hormones in humans remain unclear, these hormones are
likely to exert their effect via the preoptic area of the brain [4]. Stephenson et al.
suggested the possibility that core temperature fluctuations associated with the
menstrual cycle is due to peripheral heat dissipation [5].
During exercise, core temperature thresholds for perspiration and skin
vasodilatation are also influenced by the menstrual cycle phases as well as by resting
core body temperature [6,7]. The study of oral contraceptive administration in women
has suggested that progesterone is involved in the increase in the core temperature
threshold for heat dissipation responses that are observed in the luteal phase and that
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estradiol attenuates the effect of progesterone [3]. In addition, core temperature
thresholds for perspiration in the late follicular phase are lower than those in the early
follicular phase [8]. Thus, reproductive hormones modify thermoregulatory responses
during exercise; it appears that estrogen decreases the thresholds for perspiration and
skin vasodilatation; whereas, progesterone increases these thresholds. Although most
studies reported that the menstrual cycle had little effect on the sensitivity of the heat
dissipation reaction [3,6,8,9], Kuwahara et al. reported that the heat dissipation reaction
was weaker in the luteal phase than in the follicular phase [10]. They suggested that the
increase in progesterone levels in the luteal phase causes a decrease in plasma volume,
which then leads to decreased heat dissipation via the baroreceptor reflex during
exercise at moderate intensity and moderate temperature (25°C); however, the presence
of high heat stress (3550°C) and high exercise intensity (6085% VO2 max) may have
masked the effects of the menstrual cycle in the other studies.
With prolonged exercise under hot conditions, sweating decreases body fluid
and leads to a rise in plasma osmolarity, which consequently hampers circulatory
function [11-14]. Maintenance of body fluid levels by ingesting water during exercise
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under hot conditions suppresses the increase in body temperature and the related decline
in exercise performance [15]. Studies that have investigated the effects of the menstrual
cycle phase on cardiorespiratory responses, thermoregulation, and endurance
performance have typically been carried out either without including water ingestion
[16-19] or with water ingestion (ad libitum or controlled) during the exercise [20,21].
To our knowledge, no studies have investigated the effects of both the menstrual cycle
and water ingestion during exercise on physiological responses under hot conditions.
Therefore, in the present study, we aimed to investigate the effect of the menstrual cycle
and water ingestion on physiological responses during prolonged exercise at moderate
intensity under hot conditions.
2. Material and methods
2.1. Subjects
This study was approved by the Human Research Ethics Committee of the Faculty of
Sport Sciences of Waseda University for use of human subjects in accordance with the
Declaration of Helsinki. Eight healthy young women (age: 22.9 [SD 2.2] years; height:
159.8 [SD 3.7] cm; weight: 50.9 [SD 6.2] kg; and VO2peak: 35.8 [SD 7.3] ml·min 1·kg 1)
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with regular menstrual cycles volunteered to participate in this study. Six subjects had
not performed regular physical activities for the previous three years, whereas two other
subjects performed regular physical activities (softball and weightlifting).
2.2. Experimental design
Based on the progesterone levels, we divided the menstrual cycle into two phasesthe 
low progesterone level phase (LP) and high progesterone phase (HP)as progesterone 
levels were likely to be related to the increase in body temperature. This study
comprised four separate trials. Subjects performed two trials during the LP and two
trials during the HP. In each menstrual cycle phase, one trial was performed without
water ingestion (non-ingestion trial) and the other with water ingestion (water ingestion
trial). The phase of the menstrual cycle was determined by the basal temperature, the
day of menstruation and the serum progesterone level. We used a progesterone level of
> 5.1 ng/mL as the threshold for defining the HP [22,23]. To avoid the confounding of
phase effects by trial order, subjects were allocated randomly with different trial orders,
with four subjects starting the trials during the LP and another four subjects starting the
trials during the HP. However, the non-ingestion trial was performed before the water
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ingestion trial because the amount of water ingested during trial was determined by the
body mass loss experienced in the non-ingestion trial. Each trial was performed on a
separate day, at least 1 week apart. We asked subjects to ingest nothing except water
after 21:00 on the day before the experimental trial, and the subjects ate a standardized
breakfast (protein: 12.4 g; fat: 5.5 g; carbohydrate: 75.7 g; total energy: 395 kcal) at
6:00, which was 67 h before the trial. After breakfast, no food or beverages, except for
water, were allowed. Furthermore, we asked subjects to conduct their days similarly,
including the type and amount of food ingested on the day before the trial.
2.3. Preliminary testing
To estimate the phase of the menstrual cycle, all subjects recorded their oral temperature
upon waking every day for at least two months, as well as the day of menstruation for
three months, before commencement of the trial. Additionally, estradiol and
progesterone levels in blood samples taken before commencement of the exercise were
analyzed to confirm the menstrual cycle phase.
VO2peak was measured using a maximal graded exercise test, with an
electromagnetically braked cycle ergometer (Combi RS-232; Combi, Tokyo, Japan).
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The initial workload was 0 W for 4 min during warming up, and was increased by 30 W
every 3 min thereafter, starting at 40 W, until subjects could no longer maintain the
required pedaling frequency (70 rpm). Heart rate (HR) was monitored by
electrocardiography (Cardiosuper 2E32; Sanei-Sokki, Yamagata, Japan) throughout the
exercise. During the progressive exercise test, the gas expired by the subjects was
collected, and the rates of oxygen consumption (VO2) and carbon dioxide production
(VCO2) were measured and averaged over 30-s intervals, using an automated
breath-by-breath gas analyzer (Minato AE300; Minato Medical Science, Osaka, Japan).
VO2peak was defined as the highest 30-s value. At the end of each workload stage,
subjects were asked to indicate the rating of perceived exertion (RPE) using the Borg
scale [24]. The Borg scale consists of 15 grades from 6 to 20, with 7 = Very, very light,
9 = Very light, 11 = Fairly light, 13 = Somewhat hard, 15 = Hard, 17 = Very Hard, 19 =
Very, very hard.
2.4. Experimental trials
To minimize the potential effects of acclimatization, experiments were conducted from
February to early May. In all trials, subjects performed cycling exercise at 70 rpm,
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corresponding to a workload-estimated 50% VO2peak, for 90 min under hot conditions
(30 [SD 2] °C, 50 [SD 5] % relative humidity). The workload corresponding to 50%
VO2peak was determined from a graded exercise test by interpolation from the line of
best fit describing the relationship between power output and VO2peak. Each subject
performed a familiarization trial using the same exercise protocol as the experimental
protocol, more than one week before the experimental trial. To measure rectal
temperature during exercise, each subject inserted a rectal probe herself (401J;
Nikkeiso-YSI Co., Ltd., Musashino, Japan) to 10 cm past the anal sphincter. During
exercise, minute ventilation (VE), respiratory exchange ratio (RER), HR, and rectal
temperature were measured for 3 min each during the 4-min warm-up, and again at 15
min, 30 min, 45 min, 60 min, 75 min, and 90 min time points. Subjects were asked to
indicate their overall RPE, cardiovascular RPE, and leg RPE, to identify specific
locations of perceived exertion, at every 15-min time point from the warm-up to the end
of the 90-min cycling exercise.
During the water ingestion trial, subjects ingested water every 15 min (for a total
of 7 times) during exercise, and the total amount of water ingested equaled the body
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weight loss determined during the non-ingestion trial. The temperature of the water used
was 5 [SD 2] °C; this temperature was chosen because of the high palatability of such
water, which is known to influence fluid consumption and help prevent heat illness
during endurance exercise [25].
2.5. Blood variables and reproductive hormone level analysis
Venous blood samples were collected by venipuncture from an antecubital vein before
and after exercise. Blood samples were collected into serum separation tubes or
vacutainers containing ethylenediaminetetraacetic acid (EDTA). A fraction of whole
blood was used to measure hemoglobin and hematocrit. The blood was allowed to clot
in the serum separation tubes at room temperature for 30 min, while vacutainers
containing EDTA for plasma separation were immediately centrifuged at 1,000× g for
10 min. Serum and plasma were then removed and stored at -80ºC for subsequent
analysis. The serum concentrations of Na, osmolarity, hemoglobin, and hematocrit were
measured. The serum concentrations of estradiol and progesterone were measured using
an anti-thyroglobulin antibody (ECLIA). The reference values of estradiol levels for
non-pregnant premenopausal women, using this technique, are 2085 pg/ml in the early 
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follicular phase, 25350 pg/ml in the late follicular phase, 50550 pg/ml in the 
ovulation period, and 45300 pg/ml in the luteal phase. The reference values of
progesterone levels for non-pregnant premenopausal women, using this technique, are
<0.92 ng/ml in the follicular phase, <2.36 ng/ml during the ovulation period, and
1.2829.6 ng/ml in the luteal phase. These blood parameters were analyzed by SRI, Inc
(Tokyo, Japan).
3. Statistical analysis
All data were assessed for normal distribution using the ShapiroWilk statistic. Data for 
body weight, plasma osmotic pressure, serum sodium concentration, hemoglobin
concentration, hematocrit, plasma volume change, rectal temperature, HR, VE, and RER
were normally distributed. The estradiol data that were normally distributed after log
transformation, were analyzed using the paired t-test for each trial. Progesterone data
that were not normally distributed, were analyzed using the Wilcoxon signed-rank test
for each trial. The normally distributed data (body weight, plasma osmotic pressure,
serum sodium concentration, hemoglobin concentration, hematocrit, and plasma volume
change) were analyzed using a 2 × 2 factor (menstrual cycle phase × water condition)
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repeated analysis of variance (ANOVA). When significant menstrual cycle phase effects,
water condition effects, or interactions (menstrual cycle phase × water condition) were
evident, Bonferroni posthoc multiple comparisons were used. The differences in body
weight, plasma osmotic pressure, sodium concentration, hemoglobin concentration,
hematocrit, and plasma volume change before and after exercise were analyzed using
the paired t-test. The other normally distributed data (rectal temperature, HR, VE, and
RER during exercise) were analyzed using a 4 × 7 factor (trial × time) repeated ANOVA.
When significant trial effects or trial × time interactions were evident, we conducted
further analysis using a 2 × 7 factor (menstrual cycle phase × time) repeated ANOVA in
both water conditions and a 2 × 7 factor (water conditions × time) repeated ANOVA in
both menstrual cycle phases. Data for overall RPE, cardiovascular RPE, and leg RPE,
which were not normally distributed, were analyzed using the Kruskal-Wallis one-way 
ANOVA to determine the trial effects at specific time-points. Analyses were performed
using SPSS version 20 software for Windows (IBM Corporation, Armonk, NY, USA),
with the threshold for statistical significance set at P = 0.05. The relationships between
the dependent variables and the serum reproductive hormone levels were assessed by
establishing Pearson product-moment correlation coefficients, with the level of
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statistical significance set at P = 0.05.
4. Results
4.1. Reproductive hormones
Table 1-1 shows the serum estradiol and progesterone levels of the subjects. All subjects
exceeded the 5.1 ng/ml progesterone level set for the HP in both trials. Because the
serum progesterone level of subject No. 8 in the non-ingestion trial was out of range for
the LP, we excluded this subject and analyzed the remaining 7 subjects. Estradiol levels
during the HP were significantly higher than those during the LP only in the
non-ingestion trial (P < 0.05). Progesterone levels were significantly higher during the
HP than during the LP in each trial (P < 0.001).
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Table 1-1. Individual estradiol and progesterone levels of all subjects
Non-ingestion trial Water ingestion trial
Estradiol (pg/ml) Progesterone (ng/ml) Estradiol (pg/ml) Progesterone (ng/ml)
Subject No LP HP LP HP LP HP LP HP
1 41.0 227.0 0.57 7.10 57.0 374.0 0.56 7.80
2 45.0 66.0 0.45 5.70 67.0 264.0 0.54 6.10
3 59.0 49.0 2.18 5.20 122.0 99.0 0.61 8.20
4 116.0 185.0 0.25 5.40 288.0 263.0 0.52 6.20
5 13.0 51.0 0.57 8.20 13.0 212.0 0.57 7.10
6 26.2 122.0 0.80 5.20 225.0 108.9 1.10 6.40
7 50.6 208.0 0.20 7.30 47.2 86.7 0.10 10.10
8 51.0 46.9 4.10 9.80 242.2 151.2 0.40 16.40
Median 45.0 122.0* 0.6 5.7** 67.0 212.0 0.6 7.1**
QD 10.6 69.0 0.2 0.9 60.7 79.8 0.03 0.9
LP, low progesterone level phase; HP, high progesterone level phase; QD, quartile
deviation. Median and QD data for 7 subjects (excluding subject No. 8). *Significantly
higher than the low progesterone level phase (P < 0.05), **Significantly higher than the
low progesterone level phase (P < 0.001)
4.2. Body weight and blood variables before and after exercise
Body weight and blood variables before and after exercise are shown in Table 1-2.
There was no significant difference in body weight before exercise between the
menstrual cycle phases in each trial (Table 1-2). The body weight of the subjects were
significantly decreased during 90 min of exercise in the non-ingestion trial in both
menstrual cycle phases (P < 0.01), but were not different before and after exercise in the
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water ingestion trial. The amount of sweat estimated from body weight loss and water
ingestion during exercise was 0.92 [SD 0.38] kg during the HP and 0.77 [SD 0.22] kg
during the LP during the non-ingestion trial, and 0.98 [SD 0.59] kg during the HP and
0.74 [SD 0.37] kg during the LP during the water ingestion trial. There was no
difference between the menstrual cycle phases in each trial.
Plasma osmotic pressure was significantly increased during exercise in both
menstrual cycle phases during the non-ingestion trial (P < 0.05), whereas plasma
osmotic pressure during the water ingestion trial was not changed during the LP but
significantly decreased during the HP (P < 0.05). The plasma osmotic pressure was
significantly lower in the water ingestion trial as compared to that in the non-ingestion
trial in both menstrual cycle phases (P < 0.01). The serum sodium concentrations during
exercise were significantly increased in both phases of the non-ingestion trial, whereas
these concentrations were not changed in both phases of the water ingestion trial. The
serum sodium concentrations in the water ingestion trial were significantly lower than
those in non-ingestion trial in each menstrual cycle phase. The hemoglobin
concentration was significantly increased during exercise only during the LP of the
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non-ingestion trial. There was no difference between the menstrual cycle phases and
between the trials with regard to the hemoglobin concentration, hematocrit, and rate of
change in plasma volume before and after exercise.
Table 1-2. Body weight and blood variables before and after exercise
Non-ingestion trial Water ingestion trial
LP HP LP HP
Body weight (kg)
before 50.04 ± 4.74 50.25 ± 4.58 50.31 ± 5.04 50.53 ± 4.60
after 49.27 ± 4.69 ** 49.33 ± 4.51 ** 50.28 ± 5.18 # 50.59 ± 4.62 ##
Plasma osmotic pressure (mosmol/kg)
before 283.4 ± 3.0 279.6 ± 2.3 281.2 ± 2.8 282.4 ± 1.5
after 287.2 ± 1.6 * 284.8 ± 2.6 * 279.0 ± 2.8 ## 278.2 ± 2.8 *, ##
Serum sodium concentration (mEq/L)
before 138.8 ± 1.5 138.0 ± 0.7 138.6 ± 1.1 139.2 ± 0.4
after 140.8 ± 1.1 * 140.2 ± 1.9 * 137.8 ± 1.8 # 137.6 ± 1.3 #
Hemoglobin concentration (g/dL)
before 12.8 ± 1.0 12.9 ± 1.1 13.0 ± 1.1 12.5 ± 0.8
after 13.4 ± 1.1* 13.2 ± 0.9 13.3 ± 0.9 12.6 ± 1.0
Hematocrit (%)
before 39.0 ± 2.5 40.0 ± 2.6 39.7 ± 2.6 38.4 ± 1.3
after 40.5 ± 3.1 40.4 ± 2.3 40.3 ± 2.5 38.4 ± 2.1
Plasma volume change rate (%)
after -1.1 ± 0.8 -1.2 ± 0.7 -0.7 ± 1.3 -1.0 ± 0.6
LP, low progesterone level phase; HP, high progesterone level phase. Date shows
average ± standard deviation. *Different compared to that before exercise (P < 0.05),
**Different compared to that after exercise (P < 0.01), #Different compared to that in
the non-ingestion trial in same phase (P < 0.05), # #Different compared to that in the
non-ingestion trial in the same phase (P < 0.01)
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4.3. Rectal temperature change
Rectal temperature data during exercise are shown in Figure 1-1. There was a
significant trial × time interaction (P < 0.05), a main effect of trial (P < 0.01), and a
main effect of time (P < 0.01) according to the 4 × 7 (trial × time) two-way repeated
ANOVA. Rectal temperature during the HP was significantly higher than that in the LP
during exercise in the non-ingestion trial (P < 0.01) and in the water ingestion trial (P <
0.05). There was no menstrual cycle phase × time interaction in both water conditions.
Although a water condition × time interaction effect was noted during the HP (P < 0.05),
no main effect of water condition or water condition × time interaction was noted
during the LP.
Figure 1-1. Rectal temperature changes during exercise in hot conditions. Data are
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presented as mean ± SEM (n = 7). *Significant main effect difference according to
repeated-measures ANOVA between menstrual cycle phases in the non-ingestion trial
(P < 0.05). **Significant main effect difference according to repeated-measures
ANOVA between menstrual cycle phases in the water ingestion trial (P < 0.01).
§Significant interaction effect (water condition × time) according to the
repeated-measures ANOVA during the HP (P < 0.05). #Significant main effect of time
according to the repeated-measures ANOVA (P < 0.01). Abbreviations: HP-non, high
progesterone level phase non-ingestion trial; LP-non, low progesterone level phase
non-ingestion trial; HP-wat, high progesterone level phase water ingestion trial; LP-wat,
low progesterone level phase water ingestion trial.
4.4. Cardiorespiratory responses
The heart rate data during exercise is shown in Figure 1-2. In the 4 × 7 (trial × time)
two-way repeated ANOVA, a significant trial × time interaction (P < 0.05) and a main
effect of time (P < 0.01) were noted. There was no significant difference between the
menstrual cycle phases in both water conditions. Although a water condition × time
interaction effect was noted during the HP (P < 0.01), no main effect of water condition
or water condition × time interaction was noted during the LP. VE data during exercise
are shown in Figure 1-3. There was no trial × time interaction and no main effect of trial
according to the 4 × 7 (trial × time) two-way repeated ANOVA. Furthermore, the RER
data during exercise are shown in Figure 1-4. The 4 × 7 (trial × time) two-way repeated
ANOVA showed no trial × time interaction and no main effect of trial. PRE data are
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provided in Figure 1-5. No differences in overall RPE, cardiovascular RPE, or leg RPE
were noted among the four trials at any specific time points.
Figure 1-2. Changes in heart rate during exercise in hot conditions. Data are
presented as mean ± SEM (n = 7). §§Significant interaction effect (water conditions ×
time) during the HP according to repeated-measures ANOVA (P < 0.01). #Significant
main effect of time according to repeated-measures ANOVA (P < 0.01). Abbreviations:
HP-non, high progesterone level phase non-ingestion trial; LP-non, low progesterone
level phase non-ingestion trial; HP-wat, high progesterone level phase water ingestion
trial; LP-wat, low progesterone level phase water ingestion trial.
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Figure 1-3. Minute ventilation changes during exercise in hot conditions. Data are
presented as mean ± SEM (n = 7). Abbreviations: HP-non, high progesterone level
phase non-ingestion trial; LP-non, low progesterone level phase non-ingestion trial;
HP-wat, high progesterone level phase water ingestion trial; LP-wat, low progesterone
level phase water ingestion trial.
Figure 1-4. Changes in respiratory exchange ratio during exercise in hot conditions.
Data are presented as mean ± SEM (n = 7). Abbreviations: HP-non, high progesterone
level phase non-ingestion trial; LP-non, low progesterone level phase non-ingestion
trial; HP-wat, high progesterone level phase water ingestion trial; LP-wat, low
progesterone level phase water ingestion trial.
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Figure 1-5. Rating of perceived exertion during exercise in hot conditions. Data are
presented as mean ± SEM (n = 7). A indicates the RPE-cardiovascular, B indicates the
RPE-overall, and C indicates the RPE-legs data. The scale consists of 15 grades, from 6
to 20; 7 = Very, very light, 9 = Very light, 11 = Fairly light, 13 = Somewhat hard, 15 =
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Hard, 17 = Very Hard, 19 = Very, very hard. Abbreviations: HP-non, high progesterone
level phase non-ingestion trial; LP-non, low progesterone level phase non-ingestion
trial; HP-wat, high progesterone level phase water ingestion trial; LP-wat, low
progesterone level phase water ingestion trial.
4.5. Correlations
The Pearson correlation coefficients between variables and estradiol levels and
progesterone levels were determined. We used data from all subjects (N = 8) in this
analysis. A significant negative correlation was found between the estradiol levels and
the change in rectal temperature at 75 min (r = 0.631, P = 0.012, n = 15) and 90 min (r
= 0.770, P = 0.001, n = 15) only during the LP (all data concerning both water
conditions). The relationship between estradiol levels and the degree of increase in
rectal temperature at 90 min during the LP is shown in Figure 1-6.
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Figure 1-6. Effect of estradiol on rectal temperature in the low progesterone level
phase. The relationship between estradiol levels and the degree of increase in rectal
temperature at 90 min in the low progesterone level phase. Open triangles represent data
from individuals in the non-ingestion trial and black-filled triangles represent data from
individuals in the water ingestion trial. Abbreviations: LP-non, low progesterone level
phase non-ingestion trial; LP-wat, low progesterone level phase water ingestion trial.
5. Discussion
In the present study, we aimed to investigate the effect of the menstrual cycle phase and
water ingestion on physiological responses during prolonged exercise at moderate
intensity under hot conditions. We found that rectal temperature during the HP was
significantly higher than that in the LP during 90 min of moderate intensity exercise
regardless of the presence of water ingestion. Our result suggested that there was no
difference in the thermoregulatory responses between the menstrual cycle phases as the
rectal temperature increased at the same rate in the both phases regardless of the
presence of water ingestion. Most previous studies reported that there was no difference
between the menstrual cycle phases in terms of thermosensitivity during exercise [3,17,
18,26], whereas some studies reported that there was a difference between the menstrual
cycle phases in terms of thermosensitivity in the absence of water ingestion [16,17].
Pivarnik et al. reported a greater increase in rectal temperature in the luteal phase during
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60 min of exercise at 65% VO2max at room temperature (22 ºC) without water ingestion
[17]. In the previous study, the rectal temperature continued to increase in the luteal
phase, whereas rectal temperature reached 38.3°C after 30 min of exercise in the
follicular phase. However, the difference between the follicular phase and luteal phase
remained constant for 30 min, and the rectal temperature in the luteal phase at 30 min
was approximately 38.5°C. In the present study, rectal temperature at 90 min in the
non-ingestion trial were 38.5 [SD 0.3] °C during the HP and 38.0 [SD 0.3] °C during
the LP. Therefore, our data seem to support the findings of the previous study.
Kuwahara et al. reported a weaker thermosensitivity in the luteal phase than in the
follicular phase during 30 min of exercise at 50% VO2max at 25°C [16]. They suggest
the possibility that the lower plasma volume in the luteal phase, compared to that in the
follicular phase, led to the lower thermosensitivity in the luteal phase. In the present
study, we found that there was no difference between the LP and HP in terms of the
hematocrit and hemoglobin at rest, which suggest that there was no difference in the
plasma volume between the menstrual cycle phases. They also suggested that high level
of heat stress and higher workload would mask the influence of the menstrual cycle
phase. Thus, the difference in ambient temperature (30°C vs. 25°C) and exercise
- 29 -
duration (90 min vs. 30 min) may mask the influence of the menstrual cycle phase and
lead to a discrepancy in the result. The increase in the rectal temperature was
approximately 1.1°C in the present study but was approximately 0.4°C in previous
studies, which may be due to this discrepancy.
Garcia et al. reported that the changes in body temperature during exercise under
hot and humid conditions may be due to water ingestion, and accordingly dismissed the
difference in rectal temperature between the follicular and luteal phase; they reported
that these changes may be due to the lower urinary volume and higher sweat volume in
the luteal phase compared with the follicular phase [21]. This result may suggest that
water reabsorption in the kidney is enhanced in the luteal phase. The current results
indicate that the plasma osmotic pressure after exercise during the HP (luteal phase) in
the water ingestion trial was significantly decreased as compared to that before exercise,
which may suggest the enhancement of water reabsorption in the kidney. Hence,
although there was no difference in weight loss during the exercise between different
menstrual cycle phases (0.98 [SD, 0.58] kg during the HP and 0.74 [SD, 0.37] kg) in the
water ingestion trial, it is possible that the net sweat volume in the luteal phase was
greater than that in the follicular phase during exercise and that the heat dissipation was
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enhanced in the luteal phase during exercise with water ingestion. Our data revealed
that the average difference between the HP and LP was decreased from 0.32°C before
exercise to 0.12°C at the end of 90 min of exercise. These data may suggest that the
sweat rate was increased in the luteal phase during exercise in the presence of water
ingestion.
During the LP, water ingestion did not influence the change in rectal temperature
during 90 min of exercise. However, during the HP, water ingestion suppressed the
increase in rectal temperature during 90 min of exercise. The unique findings of this
study included the discovery of a correlation between blood estradiol levels and the
increase in rectal temperature during the LP. Moreover, a negative correlation was
observed between estradiol levels and the increase in rectal temperature after 75 min of
exercise. The mechanism underlying the effect of estradiol on rectal temperature is
believed to involve endothelial cells because the vasodilatory effect of estradiol has
been reported previously [27-29]. According to these previous studies, estradiol leads to
the production of nitric oxide via the activation of the estradiol receptor on cell
membranes in the vessel wall. We consider that the increase in blood circulation caused
by estradiol-mediated vasodilation leads to the suppression of the increase in rectal
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temperature in an estradiol level-dependent manner. However, we did not observe any
effect of estradiol-mediated vasodilatation during the HP, although this may be due to
the effect of progesterone. Furthermore, suppression of the increase in rectal
temperature led to a suppression of an increase in HR. We found a significant
correlation between the increase in rectal temperature and the increase in HR (r = 0.653,
P < 0.001, n = 32), which support the findings of previous studies [30].
6. Conclusion
During 90 min of exercise at moderate intensity under hot conditions, rectal temperature
was significantly higher during the HP than during the LP regardless of presence of
water ingestion Water ingestion is likely useful for suppressing the increase in body
temperature and HR, particularly during the HP, whereas estradiol appears to be useful
for suppressing the increase in rectal temperature during the LP.
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Chapter2. The effect of the menstrual cycle phase and carbohydrate ingestion on
inflammatory response during prolonged exercise under hot conditions
1. Background
With an increase in the number of women participating in sports for recreation, health,
fitness, weight management, social interaction, competition, and/or personal
accomplishment, the influence of menstrual cycle phase on physiologic response to
exercise has received much attention, not only for athletes but also women in general.
Sex hormones are known to regulate substrate utilization [31], muscle fatigue [32],
temperature regulation [33], and endocrine response [34] during exercise. Evaluation of
the differences in exercise response with regard to menstrual cycle phase will help
understand the menstrual cycle phasespecific adaptations to exercise and athletic
performance.
A number of studies involving male subjects have reported that exercise causes
disturbances in circulating leukocyte concentrations and function and that these effects
are dependent on the intensity of exercise and the associated release of stress hormones
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[35]. Furthermore, body temperature has been shown to affect leukocyte mobilization,
cytokines, and markers of neutrophil activation during and after exercise in men. Thus,
greater systemic mobilization was observed in a hot environment [36,37].
In women with a normal menstrual cycle, core temperature (Tc) rises by
0.3°0.5°C in the luteal phase compared to the follicular phase [1]. Therefore, we
hypothesized that a stressful condition (higher Tc and cardiorespiratory strain) in the
luteal phase would affect immune response to prolonged exercise. Although several
studies have reported the effect of exercise on immune response, very few have
investigated the effect of menstrual cycle phase. One study reported that menstrual
cycle phase did not significantly affect immune cell response (leukocytes, monocytes,
neutrophils, and lymphocytes) after 90 min of cycling at 65% maximal aerobic power
[38], However, there was no information on Tc during exercise, and it appeared that the
concentration of progesterone, which is involved in body temperature regulation, was
too low in the luteal phase.
Several studies have investigated the effect of menstrual cycle phase on
endurance exercise performance, but consistent results have not been obtained [26,39].
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One study showed that endurance performance was significantly decreased during the
luteal phase compared with the follicular phase in a hot and humid condition (32°C,
60% relative humidity), even though there was no difference between menstrual cycle
phases in a temperate condition (20°C, 45% relative humidity) [20]. One characteristic
of that study was to set a strict progesterone concentration (>5.1 ng/mL) as the criterion
threshold for definition of the luteal phase.
A number of previous studies involving male subjects reported that CHO
ingestion during exercise could suppress the mobilization of leukocytes into the
circulation [40-42] and secretion of cytokines [40, 42-45]. Ingestion of CHO during
prolonged exercise, maintains blood glucose concentration, lessens
hypothalamic-pituitary-adrenal activation and diminishes the perturbation of circulating
leukocyte concentration and function [46-48].
It is known that ovarian hormones can exert metabolic actions affecting
substrate utilization. For example, administration of estradiol and progesterone in rats
has been reported to decrease gluconeogenesis from alanine and to increase hepatic
storage [49], and variations in plasma ovarian hormones concentrations have been
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shown to alter gluconeogenesis [50]. Furthermore, animal studies show that larger lipid,
and lower CHO, utilization occurs during exercise when estrogen and progesterone, are
elevated [51,52]. Exercise substrate utilization in women throughout menstrual cycle
has generally been characterized by the measurement of respiratory exchange rate
(RER). Although discrepancies occur when studying RER in women at rest or during
exercise, some data shows the significant difference between the menstrual cycle phases.
Furthermore, previous research shows decrease of blood glucose concentration in luteal
phase compared to follicular phase during prolonged exercise [53]. This low blood
glucose concentration in the luteal phase may have a different impact on immune
response between menstrual phases during prolonged exercise.
The first purpose of our study was to examine the effect of menstrual cycle
phase on immune response to exercise in a hot condition, with a progesterone
concentration threshold for luteal phase verification. To our knowledge, the interaction
between exercise in a hot condition and menstrual cycle phase with progesterone
limitation on immune response has not been systematically studied because the exercise
conditions in previous studies were not defined. The second purpose of our study was to
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investigate the effect of CHO ingestion on immune response. We hypothesized that
menstrual cycle may affect immune responses and that CHO ingestion attenuates these
effects.
2. Material and methods
2.1. Subjects
Six healthy young women volunteered to take part in this study. All subjects maintained
a regular menstrual cycle and were not taking any oral contraceptives before testing.
Their mean characteristics were as follows: age, 23 (SD, 2.6) years; weight, 48.7 (SD,
6.1) kg; height, 156.2 (SD, 2.4) cm; and peak aerobic power (VúO2peak), 39.5 (SD, 5.3)
mL/kg/min. Four subjects had not performed regular physical activities for the previous
3 years, whereas two other subjects performed regular physical activities (e.g.
swimming).
2.2. Experimental design
This study comprised 4 separate experimental trials. Subjects exercised in the condition
(30 [SD, 2]°C and 50 [SD, 5]% relative humidity) during follicular and luteal phases of
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their menstrual cycle. During the exercise, subjects either consumed a CHO beverage
containing 3.8% CHO (2.1% glucose and 1.7% fructose) or a placebo sweetened with
an artificial sweetener (sucralose and acesulfame potassium) that tasted like the CHO
beverage. We used a hypotonic CHO beverage (osmolality 195 mOsm/kg), which was
reported to attenuate some inflammatory responses to exercise [54]. The components
and ingredients of both beverages were otherwise identical. The composition of both
beverages was as follows: protein and fat, 0 g/100 mL; sodium, 26 mg/100 mL;
potassium, 6 mg/100 mL; calcium, 1 mg/100 mL;, and magnesium, 1 mg/100 mL. Both
beverages had the same flavor and color (slightly cloudy) and were served to subjects in
a transparent plastic cup. Thus, subjects were blinded as to which beverage they were
consuming. Subjects were asked to ingest 300 mL of either beverage 30 min before
exercise and another 107 mL every 15 min during the 90-min exercise (7 times), so that
the total intake was 1,050 mL per participant. The amount and timing of intake were
determined according to the position stands of the American College of Sports
Medicine [55]. This study was approved by the Human Research Ethics Committee of
the Faculty of Sport Sciences of Waseda University for the use of human subjects in
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accordance with the Declaration of Helsinki. Prior to participation, each subject
provided her informed consent.
2.3. Preliminary testing
To estimate menstrual cycle phase, all subjects recorded their oral temperature upon
waking every day for at least 2 months and the day of menstruation for 3 months before
commencement of the trial. Additionally, blood samples taken before commencement
of the exercise were analyzed for estradiol and progesterone concentrations to determine
the menstrual phase. (VúO2peak) was measured using a maximal graded exercise test
with an electromagnetically braked cycle ergometer (Combi RS-232; Combi, Tokyo,
Japan). The initial workload was 0 W for 4 min (warming up) and was increased by
30 W every 3 min thereafter, starting at 40 W, until subjects could no longer maintain
the required pedaling frequency (70 rpm). Heart rate (HR) was monitored by
electrocardiography (Cardiosuper 2E32; Sanei-Sokki, Yamagata, Japan) throughout the
exercise. During the progressive exercise test, the expired gas of subjects was collected,
and the rates of oxygen consumption (VúO2) and carbon dioxide production VúCO2 were
measured and averaged over 30-s intervals using an automated breath-by-breath gas
analyzer (Minato AE300; Minato Medical Science, Osaka, Japan). VúO2peak was
defined as the highest 30-s value. At the end of each workload stage, subjects were
asked to indicate the rating of perceived exertion (RPE) by using the Borg Scale [24].
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2.4. Experimental trials
All subjects completed four separate experimental trials, with each trial occurring at a
specific time during the menstrual cycle, previously determined for each subject by her
basal body temperature. For the 2 CHO and 2 placebo trials, 1 trial each occurred in the
follicular phase (FC and FA, respectively), and 1 trial each in the luteal phase (LC and
LA, respectively). To avoid a confounding phase and beverage effect with trial order,
subjects were randomly assigned trial orders, with 3 subjects commencing in the
follicular phase and 3 in the luteal phase. Each experimental trial was performed on a
separate day at least 1 week apart. Subjects were asked to only drink water after 21:00 h
on the day before the experimental trial, and they ate a standardized breakfast (protein,
12.4 g; fat, 5.5 g; CHO, 75.7 g; and total energy, 395 kcal) at 06:00 h, i.e. 67 h before 
each trial. Thereafter, foods and beverages, except for water, were not allowed.
In all 4 trials, subjects cycled at 50% VúO2peak (60 [SD, 12.2] W) for 90 min in
a hot condition (30 [SD, 2]°C and 50 [SD, 5]% relative humidity) and completed POST.
The workload corresponding to 50% VúO2peak was determined from the graded
exercise test by interpolation from the line of the best fit describing the relationship
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between power output and VúO2. During endurance sports competitions, such as
marathons, many participants attempt sprints in the final stage of the race. Therefore, in
order to simulate an actual competition, our experimental protocol comprised of 2 parts:
90 min of cycling exercise at moderate intensity and a timed performance test. This
study composed of a prolonged exercise and performance test under hot condition by
untrained subjects. We set exercise intensity at 50% VúO2peak, which was lower than
the 65% VúO2max and room temperature condition set in the previous study [9] because
we thought that the 65% VúO2max intensity under hot condition would be too strenuous
for untrained subjects. To measure rectal temperature during the exercise, subjects
self-inserted a rectal probe (401 J; Nikkeiso-YSI Co. Ltd., Musashino, Japan) 10 cm
past the anal sphincter. During exercise, minute ventilation (VúE), expired gas
concentration, HR, and rectal temperature were measured for 3 min at the 4-min
(warm-up), 15-min, 30-min, 45-min, 60-min, 75-min, and 90-min time points. Subjects
were asked to indicate their overall RPE, RPE-cardiovascular, and RPE-legs to identify
specific locations of perceived exertion at every 15-min time point from the warm-up to
the end of the 90-min cycling exercise.
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Following the 90-min exercise, subjects completed POST that lasted
approximately 10 min in the same condition. Subjects were required to complete a set
amount of work (52.4 [SD, 8.6] kJ) as fast as possible. The total amount of work to be
performed was calculated using the following formula [56]: Total work (J)= 0.65
Wpeak × 600. Wpeak (134.4 [SD, 22] W) was the maximal workload capacity
determined in preliminary testing and 600 was the duration in seconds (equivalent to
10 min). The ergometer was connected to a computer that calculated and displayed the
total amount of work performed. Subjects received only information on the percentage
of work performed relative to the set amount of work from the examiner. A
familiarization trial was also completed before commencement to allow subjects to
familiarize themselves with the protocol and laboratory setting.
2.5. Blood sampling and analysis
Venous blood samples were collected by venipuncture from an antecubital vein before
exercise (PRE); at the 30-min, 60-min, and 90-min time points during the exercise; and
at POST. Blood samples were collected into serum separation tubes or vacutainers
containing ethylenediaminetetraacetic acid (EDTA). A fraction of whole blood was
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used to measure hemoglobin, hematocrit, and full blood cell count. Serum separation
tubes were left to allow blood to clot at room temperature for 30 min, while vacutainers
containing EDTA for plasma separation were immediately centrifuged at 1,000 × g for
10 min. Serum and plasma were then removed and stored at -80°C for future analysis.
Serum free fatty acid and plasma glucose concentrations, leukocyte concentrations,
hemoglobin, and hematocrit were analyzed by BML, Inc. (Tokyo, Japan). Commercial
enzyme-linked immunosorbent assay (ELISA) kits were used to measure plasma
concentrations of the cytokines interleukin (IL)-1 , IL-1 receptor antagonist (IL-1ra),
IL-6, tumor necrosis factor (TNF)- (R&D Systems, Minneapolis, MN), IL-8, IL-10,
and IL-12p40 (Becton Dickinson Bioscience, San Diego, CA), and the neutrophil
activation markers myeloperoxidase (MPO) and calprotectin (HyCult Biotechnology,
Uden, the Netherlands). ELISA measurements were performed according to the
instructions for each ELISA kit using a microplate reader (VERSAmax; Molecular
Devices, Sunnyvale, CA). Plasma concentrations of all these variables were adjusted for
changes in plasma volume [57].
2.6. Statistical analysis
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All data were checked for normal distribution using the Kolmogorov-Smirnov statistic.
Data for rectal temperature, HR, VE, RER, blood glucose, serum free fatty acid,
leukocyte concentrations, and performance test result were normally distributed. Data
for serum sex hormones, IL-8, IL-12p40, and MPO concentrations were normally
distributed after log transformation. Data for serum IL-1 , IL-1ra, IL-6, IL-10,
calprotectin, and TNF- concentrations were not normally distributed. Normally
distributed data (sex hormones and POST result were analyzed using a 2× 2 factor
(menstrual cycle phase × beverage) repeated analysis of variance (ANOVA). For other
normally distributed data (rectal temperature, HR, and RER), a 4× 8 factor (trial× time)
repeated ANOVA was used to determine trial effects, time effects, and trial × time
interactions. For other normally distributed data (blood glucose, free fatty acid,
leukocyte concentrations, IL-8, IL-12p40, and MPO), a 4× 5 factor (trial× time)
repeated ANOVA was used to determine trial effects, time effects, and trial × time
interactions. When significant trial effects, time effects, or trial× time interactions were
evident, Bonferroni posthoc multiple comparisons were used. Data for serum IL-1 ,
IL-1ra, IL-6, IL-10, calprotectin, and TNF- were analyzed using nonparametric
Friedmans ANOVA on ranks test to determine time effects. Kruskal-Wallis one-way 
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ANOVA was used to assess differences between trials at specific time points. Data were
analyzed using SPSS version 19 for Windows (IBM Corporation, Armonk, NY) with
the threshold for statistical significance set at P= 0.05. Relationships between dependent
variables and leukocyte concentration were assessed with Pearson product correlations.
The level of statistical significance was set at P< 0.05.
3. Results
3.1. Hormones
Table 2-1 shows the serum estradiol and progesterone concentrations of all subjects.
Menstrual cycle phase × beverage did not affect serum estradiol and progesterone
concentrations. A main effect of menstrual cycle phase (P < 0.01), but not of the
beverage, on both hormones was observed. Serum estradiol and progesterone
concentrations were significantly higher in the luteal phase than in the follicular phase
[58]. We used the progesterone concentration limit 5.1 ng/mL for luteal phase
verification according to previous studies [20,23].
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Table 2-1. Resting hormone concentration of subjects before each trial
FA LA FC LC
Subject
[E]
(pg/mL)
[P]
(ng/mL)
[E]
(pg/mL)
[P]
(ng/mL)
[E]
(pg/mL)
[P]
(ng/mL)
[E]
(pg/mL)
[P]
(ng/mL)
1 33.4 0.2 171.4 18.9 163.7 0.3 321.3 15.7
2 34.8 0.2 125.5 10.4 42.7 0.1 98.5 7.4
3 30.8 0.4 94.0 6.0 39.4 0.2 68.3 5.7
4 47.3 0.1 108.9 6.4 83.8 1.4 171.0 14.9
5 50.6 0.2 201.4 13.2 98.0 0.2 327.4 19.9
6 201.0 0.4 151.2 25.6 44.0 0.4 102.1 9.1
mean 66.3 0.3 142.1 13.4 78.6 0.4 181.4 12.1
SD 66.5 0.1 40.4 7.0 48.3 0.4 115.7 5.1
Abbreviations: FA, follicular phase placebo trial; LA, luteal phase placebo trial; FC, follicular
phase carbohydrate trial; LC, luteal phase carbohydrate trial. [E], estradiol concentration; [P],
progesterone concentration.
3.2. Physiologic response
Rectal temperature data during exercise is shown in Figure 2-1. The results show that
menstrual cycle phase and beverage type had significant effect on rectal temperature
during exercise (P< 0.05). Although there was a significant difference within a trial,
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there was no significant difference between the trials. Rectal temperature was
significantly increased over time during exercise (P< 0.01).
Figure 2-1. Rectal temperature during cycling exercise
Data are mean ± SEM (n = 6). *Significant repeated-measures ANOVA main effect
difference between the trials (P < 0.05). #Significant repeated-measures ANOVA main
effect in time (P < 0.01). Abbreviations: FA, follicular phase placebo trial; FC, follicular
phase carbohydrate trial; LA, luteal phase placebo trial; LC, luteal phase carbohydrate
trial; PRE, before exercise.
Table 2-2 shows cardiorespiratory measures. The results show that menstrual
cycle and beverage type had no significant effect on HR, VúE, and RER. However HR
and VúE significantly increased to over time during exercise (P < 0.01). RER
significantly changed over time during exercise (P < 0.01). Furthermore, there was no
significant effect of menstrual cycle phase or beverage type on RPE data (data not
shown).The total amount of CHO consumed in the CHO trials (FC and LC) was 40 g.
Plasma glucose and free fatty acid data are shown in Figure 2-2. There was no
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trial× time interaction with respect to change in glucose; however, there was a main
effect in trial (P < 0.05) and time (P< 0.01). Blood glucose at 90 min in the LA was
significantly lower than that in the LC (P < 0.05), and a lower trend compared with that
in the FC (P< 0.068).
There was a trial× time interaction (P < 0.05), a main effect in time (P< 0.01),
and a trend in trial (P = 0.082) in serum free fatty acid. The concentration at POST in the
LA was significantly higher compared with that in the FC (P< 0.01).
Table 2-2. Cardiorespiratory measures during 90 min exercise
Trial 4 min 15 min 30 min 45 min 60 min 75 min 90 min
FA 80 ± 50 131 ± 11 138 ± 12 140 ± 12 145 ± 12 149 ± 15 154 ± 15
FC 83 ± 12 134 ± 14 143 ± 17 145 ± 20 148 ± 19 153 ± 21 156 ± 21
LA 82 ± 40 137 ± 90 142 ± 11 149 ± 13 148 ± 18 154 ± 13 156 ± 17
HR
(beat/min)
LC 91 ± 16 141 ± 12 149 ± 12 150 ± 12 153 ± 15 154 ± 14 156 ± 14
FA 11.1 ± 1.3 28.4 ± 2.4 29.6 ± 3.4 28.4 ± 4.5 29.8 ± 3.8 29.5 ± 3.3 29.8 ± 3.0
FC 10.9 ± 1.0 28.7 ± 2.6 29.5 ± 2.3 28.9 ± 3.1 28.6 ± 2.3 30.0 ± 3.3 30.6 ± 3.5
LA 10.9 ± 2.6 28.9 ± 1.9 30.1 ± 2.4 30.2 ± 4.0 31.0 ± 4.3 32.5 ± 4.9 33.2 ± 6.1
VE
(L/min)
LC 12.1 ± 1.0 29.1 ± 5.4 30.4 ± 3.4 30.5 ± 4.3 30.4 ± 4.5 30.7 ± 4.5 31.9 ± 4.8
FA 0.81 ± 0.04 0.88 ± 0.03 0.88 ± 0.03 0.83 ± 0.05 0.84 ± 0.04 0.82 ± 0.04 0.80 ± 0.04
FC 0.83 ± 0.08 0.89 ± 0.04 0.87 ± 0.04 0.83 ± 0.04 0.82 ± 0.04 0.82 ± 0.04 0.81 ± 0.04
LA 0.84 ± 0.05 0.90 ± 0.07 0.89 ± 0.06 0.86 ± 0.08 0.85 ± 0.06 0.85 ± 0.07 0.84 ± 0.08
RER
LC 0.85 ± 0.11 0.89 ± 0.06 0.88 ± 0.05 0.86 ± 0.04 0.85 ± 0.05 0.84 ± 0.05 0.84 ± 0.05
Dates are shown as mean ± SD. Abbreviations: FA, follicular phase placebo trial; FC,
follicular phase carbohydrate trial; IL, interleukin; LA, luteal phase placebo trial; LC,
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luteal phase carbohydrate trial; HR, heart rate; VE, minute ventilation; RER, respiratory
exchange rate.
3.3. Inflammatory response
Leukocyte concentration data are shown in Figure 2-3. There was a trial× time
interaction (P < 0.01), and a main effect in trial (P< 0.01) and time in leukocyte
concentration (P< 0.01). Leukocyte concentration at 90 min in the LA was significantly
higher than that in the FC (P < 0.01), and that at POST in the LA were significantly
higher than those in the FA (P< 0.05), LC (P < 0.01), and FC (P < 0.01). Leukocyte
concentrations at 90 min in the LA was higher than those in the FA (P= 0.073) and LC
(P= 0.098). Moreover, leukocyte concentrations at POST in the FA were significantly
higher than those in the FC (P < 0.01). Pearsons correlation coefficient between serum 
free fatty acid concentration and leukocyte concentration was determined, and a
significant positive correlation was found (r= 0.661, P< 0.001).Serum cytokine
concentration data are shown in Table 2-3. Serum IL-6 concentrations were
significantly higher at 90 min (P< 0.05) and POST (P < 0.01) from PRE in 3 trials (FA,
LA, and LC). Moreover, the concentrations at POST in these 3 trials were significantly
higher (P< 0.01) than those at 30 min. In the FC trial, the concentration at POST was
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significantly higher compared with that at PRE and 30 min. However, there were no
significant differences between the trials at any time point. Serum MPO concentrations
were highest at POST in all trials. There was a main effect in time (P < 0.01), but no
trial× time interaction or main effect in trial. Serum calprotectin concentrations were
significantly higher (P<0.01) at POST from PRE in all 4 trials. The concentrations at
POST in the FC (P < 0.05), LA (P< 0.01), and LC (P< 0.05) were higher than those at
30 min. Moreover, the concentrations at 90 min in the FC (P< 0.01), LA (P < 0.01), and
LC (P < 0.05) were significantly higher than those at PRE.
Serum IL-1 , IL-1ra, IL-8, IL-10, IL-12p40, and TNF- concentrations
remained unchanged following the exercise in all 4 trials, and no significant differences
were observed between trials.
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Figure 2-2. Blood glucose and serum free fatty acid concentrations.
Data are mean ± SEM. *Significant repeated-measures ANOVA main effect difference
between the trials (P < 0.05). #Significant repeated-measures ANOVA main effect in
time (P < 0.01). aSignificantly different between LA and LC (P < 0.05) §Significant
repeated-measures ANOVA interaction between trial and time (P < 0.05). bSignificantly
different between LA and FC (P < 0.01). Abbreviations: FA, follicular phase placebo
trial; FC, follicular phase carbohydrate trial; LA, luteal phase placebo trial; LC, luteal
phase carbohydrate trial; PRE, before exercise; POST, high intensity time trial
performance test.
Figure 2-3. Leukocyte concentration during exercise and after performance test.
Data are mean ± SEM. **Significant repeated-measures ANOVA a trial × time
interaction (P < 0.01). §§Significant repeated-measures ANOVA main effect difference
between the trials (P < 0.01). #Significant repeated-measures ANOVA main effect
difference in time (P < 0.01).aSignificantly different between LA and FA (P < 0.05).
bSignificantly different between LA and LC (P < 0.01). cSignificantly different between
LA and FC (P < 0.01). dSignificantly different between FA and FC (P < 0.01).
Abbreviations: FA, follicular phase placebo trial; FC, follicular phase carbohydrate trial;
LA, luteal phase placebo trial; LC, luteal phase carbohydrate trial; PRE, before exercise;
POST, high intensity time trial performance test.
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Table 2-3. Serum cytokine concentrations
PRE 30 min 60 min 90 min POST
IL-1 (pg/mL)
FA
FC
LA
LC
0.9 3.0
0.9 3.9
0.9 3.1
1.2 2.5
0.9 2.5
1.0 4.9
1.0 2.8
1.1 2.7
1.0 3.2
1.0 3.3
0.8 2.8
0.9 2.4
0.9 2.8
1.2 3.7
1.1 3.0
1.1 2.7
0.7 2.9
1.4 3.3
1.1 2.8
1.3 2.2
IL-1ra (pg/mL)
FA
FC
LA
LC
186 109
159 59
203 103
234 117
196 131
173 51
200 100
219 138
203 154
234 95
202 83
209 81
256 77
214 121
196 61
224 125
267 130
212 89
269 152
177 115
IL-6 (pg/mL)
FA
FC
LA
LC
0.2 1.5
0.1 0.5
0.2 0.2
0.2 0.4
0.1 1.3
0.2 0.3
0.2 0.1
0.2 0.2
0.6 2.3
0.8 1.5
0.5 0.8
0.9 1.2
2.6 3.9a
1.9 3.6
1.5 4.0a
2.3 2.0a,c
6.3 12.9b,d
2.9 8.8a,c
2.2 9.2b,d
4.0 6.6b,d
IL-8 (pg/mL)
FA
FC
LA
LC
1.2 0.5
1.5 0.5
0.8 0.4
1.1 0.4
1.5 0.5
1.3 0.5
1.1 0.4
1.5 0.6
1.3 0.7
1.0 0.4
1.2 0.7
1.1 0.5
1.7 0.7
1.5 0.5
1.2 0.4
1.6 0.9
2.0 0.9
1.4 0.6
1.1 0.5
1.8 0.7
IL-10 (pg/mL)
FA
FC
LA
LC
5.3 4.1
2.6 2.3
4.5 8.5
3.4 3.5
3.8 3.8
3.0 5.0
3.3 2.4
3.7 3.5
5.1 3.8
3.2 1.3
3.5 3.2
3.9 5.6
4.2 1.6
2.5 2.7
3.5 3.0
3.7 2.4
2.8 2.0
2.9 3.2
4.9 3.4
3.4 2.5
IL-12p40 (pg/mL)
FA
FC
LA
37 8
29 5
43 7
44 11
36 4
37 6
36 6
43 8
32 4
38 9
27 6
30 10
43 5
36 6
35 5
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LC 32 8 32 3 33 3 30 3 34 4
Calprotectin (ng/mL)
FA
FC
LA
LC
21 14
18 46
23 32
26 17
26 19
21 121
42 29
40 45
27 24
25 137
62 67
60 53
47 28
39 196b
170 181b
64 42a
95 147b
43 267b,c
240 117b,d
103 276b,c
MPO (ng/mL)
FA
FC
LA
LC
17 2
20 5
10 2
17 2
20 3
26 8
26 4
21 3
20 1
25 5
24 2
19 3
27 4
38 13
34 3
30 7
46 11 e
39 9
46 5
34 8
TNF- (pg/mL)
FA
FC
LA
LC
0.3 0.2
0.3 0.2
0.3 0.1
0.3 0.1
0.3 0.1
0.3 0.2
0.3 0.1
0.3 0.1
0.3 0.1
0.3 0.2
0.3 0.1
0.2 0.1
0.3 0.1
0.3 0.1
0.3 0.1
0.3 0.1
0.4 0.2
0.3 0.1
0.3 0.1
0.3 0.1
Data for IL-8, IL-12p40 and MPO are shown as mean SEM; data for IL-1 , IL-1ra,
IL-6, IL-10, Calprotectin and TNF- are shown as median quartile deviation
aSignificantly different from PRE (P < 0.05). bSignificantly different from PRE (P <
0.01). cSignificantly different from 30 min (P < 0.05). dSignificantly different from 30
min (P < 0.01). eMain effect in time (P < 0.01).
Abbreviations: FA, follicular phase placebo trial; FC, follicular phase carbohydrate trial;
IL, interleukin; LA, luteal phase placebo trial; LC, luteal phase carbohydrate trial; MPO,
myeloperoxidase; POST, high intensity time trial performance test; PRE, before
exercise; TNF, tumor necrosis factor.
3.4. Performance test
The mean time (s) required to complete POST was 675 (SD, 163) in the FA, 681 (SD,
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147) in the LA, 692 (SD, 156) in the FC, and 678 (SD, 180) in the LC, respectively.
There were no significant differences between trials. Subjects indicated an RPE of 20
for all trials at POST.
4. Discussion
The first purpose of the present study was to investigate the effect of menstrual cycle
phase on immune response to exercise. The results showed that menstrual cycle phase
affected leukocyte concentrations in response to prolonged exercise; leukocyte
mobilization in the luteal phase was larger compared to that in the follicular phase at
90 min of cycling and at POST while ingesting a placebo beverage. However, there was
no significant effect of menstrual cycle phase on serum cytokine concentrations. Thus,
these results partially supported our hypothesis.
The second purpose of this study was to investigate whether CHO ingestion has
an effect on immune response to prolonged exercise. The results showed that ingesting
a CHO beverage attenuated leukocyte mobilization and eliminated the differences
between menstrual cycle phases observed in the placebo beverage trials. However, there
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was no effect of CHO ingestion on serum cytokine concentrations, which partially
supported our hypothesis.
A previous study showed that there was no significant difference in total
leukocyte concentration between menstrual cycle phases after 90 min of cycling
exercise [38]. The reason for the conflicting results between the previous and present
study may be difference in the range of progesterone concentrations (10.3 [SD, 8.3]
nmol/L) in the luteal phase. This range indicates that most subjects had a lower
progesterone concentration than the 16 nmol/L limit, which may have weakened the
effect of progesterone on body temperature [20]. However, the correlation between Tc
and immune response could not be determined because no information on Tc was
available in the previous study.
It is well known that there is a substantial increase in leukocyte concentration
(mainly neutrophils) during endurance exercise, and this increase depends on the
intensity and duration of exercise [59]. It has been shown that the elevation of
neutrophils is due to several hormones (e.g., epinephrine, cortisol, growth hormone, and
prolactin) that are known to have immunomodulatory effects [60]. We hypothesized
- 55 -
that higher Tc and potentially increased cardiorespiratory strain in the luteal phase
would result in a disturbance in immune response. However, the results of this study
showed that there were no significant differences in cardiorespiratory responses
between menstrual cycle phases even though thermoregulatory response was
significantly different between menstrual cycle phases. Therefore, we thought that
causes other than Tc and cardiorespiratory strain could increase leukocyte
concentrations in the luteal phase.
Some studies have found that menstrual cycle phase does indeed affect
hormonal and metabolic responses to exercise [61,62], particularly in a CHO-depleted
nutrition state [53,63]. It is possible that high concentrations of sex hormones in the
luteal phase decrease gluconeogenesis and blood glucose concentrations, which, in turn,
may lead to an increase in circulating cortisol concentrations and leukocytosis. In this
study, the blood glucose concentration at 90 min in the LA trial was lower compared
with that in the other trials. Moreover, the high correlation between serum free fatty
acid concentration and leukocyte concentration may suggest this mechanism. It is
possible that the CHO beverage maintained blood glucose concentrations and prevented
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the mobilization of stress hormones that cause leukocytosis. Thus, the increase in
leukocyte concentration in the LA might be due to the combined effect of exercise and
differential substrate metabolism by sex hormones.
Previous studies on male subjects have consistently reported that ingesting CHO
during exercise suppresses the rise in circulating neutrophils, most likely by reducing
the secretion of stress hormones that regulate neutrophil mobilization by maintaining
high blood glucose [40-42]. The results of this study may support these previous
studies.
Muscle-derived IL-6 appears to be at least partly responsible for the elevated
secretion of cortisol during endurance exercise. Infusion of recombinant human IL-6
into resting humans to mimic the exercise-induced plasma concentrations of IL-6 has
been shown to increase plasma cortisol in a similar manner [60,64]. In this study, an
increase in IL-6 concentration was observed in all trials, but there were no significant
differences between menstrual cycle phases or CHO ingestion at any time point. These
results suggest that factors other than IL-6 may be more related to changes in leukocyte
concentrations, consistent with a previous study [38].
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Most [40,42,44,48,65], but not all, studies [45,66,67] report that carbohydrate
ingestion attenuates plasma IL-6 concentration following exercise. The increase in
plasma IL-6 concentration observed following all trials in our study could be due to
release of IL-6 from the skeletal muscle [68,69]. However, consistent plasma IL-6
concentration between trials was most likely due to consistent release of IL-6 from the
skeletal muscle during exercise and suggests that there was no difference in muscle
glycogen concentration [70].
Elevated serum MPO concentration after exercise likely reflects neutrophil
degranulation because MPO is contained in azurophilic granules within neutrophils.
MPO is an important contributor to neutrophil microbicidal activity. Serum MPO
concentration depends on exercise intensity [71] and temperature [36]. In the present
study, serum MPO concentration was significantly increased at POST compared with
PRE, but there were no significant differences between trials. In this study, consistent
with other findings [72], CHO intake did not influence change in serum MPO
concentration.
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Calprotectin is secreted from monocytes and neutrophils in response to a variety
of inflammatory conditions [73]. In the present study, serum calprotectin concentration
was significantly increased at POST compared with PRE, but there were no significant
differences between trials. These results are in agreement with a previous study, in
which the effect of heat stress during exercise on change in serum calprotectin
concentration was reported [36]. The mechanisms regulating calprotectin release and
the biological role of calprotectin during exercise are currently uncertain. We
incorporated the POST in the experimental protocol assuming that participants would
attempt a sprint similar to that in actual competitions. The study results show that
menstrual cycle phase and beverage type had no significant effect on the timed
performance test. In this study, cardiorespiratory responses were not significantly
different between trials; therefore, no differences in performance between trials could
be observed. This result supports a previous study [20], in which menstrual cycle phase
did not affect the endurance performance at moderate temperatures.
One of the limitations of this study is the absence of cortisol, growth hormone,
catecholamine, and muscle glycogen measurements during exercise, which would have
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allowed a better understanding of the relationships among hormone concentrations,
glucose availability, and differential leukocyte concentrations. Even though we found
that menstrual cycle phase significantly affected leukocyte concentration, we cannot
rule out the possibility that the small cohort of subjects used in this study might have
had a negative impact on some of the other measurements, rendering them
non-significant. The small number of subjects may not have provided adequate
statistical power to detect real, but relatively small, differences in some of the measured
variables.
5. Conclusion
Menstrual cycle phase affected circulating leukocyte concentrations during endurance
exercise while ingesting a placebo. The degree of leukocyte mobilization was greater in
the luteal phase compared with the follicular phase. Ingestion of the CHO beverage
eliminated the effect of menstrual cycle phase on leukocyte concentration, which may
be explained by the effect of sex hormones on substrate utilization. However, there was
no effect of menstrual cycle phase on cytokines during exercise.
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The results of this study demonstrate that menstrual cycle changes do alter
leukocyte concentration during exercise when subjects consume CHO beverage. Indeed,
as the placebo trials progressed, differences became more pronounced, indicating that as
endogenous CHO reserves were depleted the effect of menstrual cycle changes become
more evident. This was further supported by the absences of difference in immune
response between the FC and LC trials.
In women undergoing endurance training for recreational purposes, prolonged
exercise in the luteal phase may lead to larger immune disturbances compared to the
follicular phase if they ingest water alone during the duration of the exercise. Therefore,
we recommend ingesting carbohydrate beverages to attenuate immune disturbances
especially in the luteal phase, even though they are unlikely to enhance test performance.
However, the total subject number is small and does not constitute a representative
sample, and the results need further validation using larger cohorts.
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Concluding remarks
This study revealed that water ingestion may be useful to suppress the increase in body
temperature, especially during the luteal phase (high progesterone level phase) during
prolonged exercise under hot. Furthermore, this study suggested that the disturbance of
inflammatory response observed during the luteal phase during prolonged exercise
under hot conditions is suppressed by carbohydrate ingestion.
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